A vaccine created by the Swiss drug maker, Novartis, is being used on college campuses in the U.S, AP reports.
The drug is a preventative against meningitis B. The University of California Santa Barbara is using the vaccine Bexsero until March 7 to help protect 20,000 students and staff after an outbreak, according to Novartis.
The Food and Drug Administration approved the use of Bexsero twice in response to outbreaks of meningitis on U.S. college campuses.
The vaccine, which is a shot used for the B strain of the meningitis bacteria, is approved for use in Europe, Australia, and Canada, but has not yet been approved for general use in the U.S.
Read the full story here: Novartis meningitis vaccine used at 2nd US campus